{"id":728907,"date":"2023-02-06T09:05:50","date_gmt":"2023-02-06T14:05:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/"},"modified":"2023-02-06T09:05:50","modified_gmt":"2023-02-06T14:05:50","slug":"sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/","title":{"rendered":"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Feb.  06, 2023  (GLOBE NEWSWIRE) &#8212; Sharps Technology, Inc. (the \u201cCompany\u201d, &#8220;Sharps&#8221;) (NASDAQ: \u201cSTSS\u201d and \u201cSTSSW\u201d), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with institutional investors on February 3, 2023. The aggregate gross proceeds of the private placement were approximately $3.8 million priced at the market under Nasdaq rules. Proceeds will help support the manufacturing of pre-filled specialty syringe systems through its partnership with Nephron Pharmaceuticals.<\/p>\n<p>In connection with the offering, the Company issued 2,248,521 units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules. Each unit consists of one share of common stock and one non-tradable warrant exercisable for one share of common stock at a price of $1.56. The warrants have a term of five years from the issuance date. Gross proceeds were $3.8 million before deducting fees to the placement agent and other offering expenses payable by the Company.<\/p>\n<p>\n        <strong>Aegis Capital Corp. acted as the Exclusive Placement Agent in connection with the offering<\/strong>.<\/p>\n<p>The securities described above were sold in a private placement and have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (the \u201cSEC\u201d) or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investors, the Company has agreed to file one or more registration statements with the SEC covering the resale of the common stock and the common stock issuable upon exercise of the warrants.<\/p>\n<p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.<\/p>\n<p>\n        <strong>About Sharps Technology<\/strong>\n      <\/p>\n<p>Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The company\u2019s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and ready to use processing. The company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US. For additional information, please visit www.sharpstechnology.com.<\/p>\n<p>\n        <strong>Forward-Looking Statements:<\/strong>\n      <\/p>\n<p>This press release contains \u201cforward-looking statements\u201d Forward-looking statements reflect our current view about future events. When used in this press release, the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cplan,\u201d or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity, and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy, and other future conditions. Because forward\u2013looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.<\/p>\n<p>\n        <strong>Investor Relations:<\/strong>\n      <\/p>\n<p>US Investor Relations:<br \/>Adam Holdsworth, Managing Director<br \/>TraDigital IR<br \/>adam@tradigitalir.com<\/p>\n<p>Or<\/p>\n<p>\n        <strong>Investor Relations:<br \/><\/strong>Dave Gentry<br \/>RedChip Companies Inc.<br \/>1-800-RED-CHIP (733-2447)<br \/>Or 407-491-4498<br \/>STSS@redchip.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OWNkOTA0ZjYtOGY3NC00ZmRlLTg3ODktNWM2MGZjMjc0MGVkLTEyNTg3MTQ=\/tiny\/Sharps-Technology-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Sharps Technology, Inc. (the \u201cCompany\u201d, &#8220;Sharps&#8221;) (NASDAQ: \u201cSTSS\u201d and \u201cSTSSW\u201d), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with institutional investors on February 3, 2023. The aggregate gross proceeds of the private placement were approximately $3.8 million priced at the market under Nasdaq rules. Proceeds will help support the manufacturing of pre-filled specialty syringe systems through its partnership with Nephron Pharmaceuticals. In connection with the offering, the Company issued 2,248,521 units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules. Each unit consists of one share of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-728907","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Sharps Technology, Inc. (the \u201cCompany\u201d, &#8220;Sharps&#8221;) (NASDAQ: \u201cSTSS\u201d and \u201cSTSSW\u201d), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with institutional investors on February 3, 2023. The aggregate gross proceeds of the private placement were approximately $3.8 million priced at the market under Nasdaq rules. Proceeds will help support the manufacturing of pre-filled specialty syringe systems through its partnership with Nephron Pharmaceuticals. In connection with the offering, the Company issued 2,248,521 units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules. Each unit consists of one share of &hellip; Continue reading &quot;Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-06T14:05:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market\",\"datePublished\":\"2023-02-06T14:05:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/\"},\"wordCount\":816,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/\",\"name\":\"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=\",\"datePublished\":\"2023-02-06T14:05:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/","og_locale":"en_US","og_type":"article","og_title":"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market - Market Newsdesk","og_description":"NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Sharps Technology, Inc. (the \u201cCompany\u201d, &#8220;Sharps&#8221;) (NASDAQ: \u201cSTSS\u201d and \u201cSTSSW\u201d), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with institutional investors on February 3, 2023. The aggregate gross proceeds of the private placement were approximately $3.8 million priced at the market under Nasdaq rules. Proceeds will help support the manufacturing of pre-filled specialty syringe systems through its partnership with Nephron Pharmaceuticals. In connection with the offering, the Company issued 2,248,521 units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules. Each unit consists of one share of &hellip; Continue reading \"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-06T14:05:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market","datePublished":"2023-02-06T14:05:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/"},"wordCount":816,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/","name":"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=","datePublished":"2023-02-06T14:05:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzQ3NSM1MzkzNDkxIzIyNDcxNjE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sharps-technology-announces-closing-of-3-8-million-private-placement-priced-at-the-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=728907"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728907\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=728907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=728907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=728907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}